Anti-inflammatory for critical care patients focus of $6 million fundraise
A company is raising $6 million to advance the development of a natural human protein with anti-inflammatory benefits for critical care patients. BioAegis Therapeutics is developing recombinant human plasma gelsolin to restore plasma gelsolin levels in patients where it is depleted. As of last month it had raised about $500,000. The compelling characteristic of plasma […]